1. Home
  2. VIVS vs ICON Comparison

VIVS vs ICON Comparison

Compare VIVS & ICON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIVS
  • ICON
  • Stock Information
  • Founded
  • VIVS 2007
  • ICON 2023
  • Country
  • VIVS United States
  • ICON Greece
  • Employees
  • VIVS N/A
  • ICON N/A
  • Industry
  • VIVS Biotechnology: Biological Products (No Diagnostic Substances)
  • ICON
  • Sector
  • VIVS Health Care
  • ICON
  • Exchange
  • VIVS Nasdaq
  • ICON Nasdaq
  • Market Cap
  • VIVS 4.2M
  • ICON 3.9M
  • IPO Year
  • VIVS N/A
  • ICON 2024
  • Fundamental
  • Price
  • VIVS $1.45
  • ICON $2.31
  • Analyst Decision
  • VIVS
  • ICON Strong Buy
  • Analyst Count
  • VIVS 0
  • ICON 1
  • Target Price
  • VIVS N/A
  • ICON $4.50
  • AVG Volume (30 Days)
  • VIVS 64.3K
  • ICON 3.3M
  • Earning Date
  • VIVS 07-07-2025
  • ICON 04-23-2025
  • Dividend Yield
  • VIVS N/A
  • ICON 100.00%
  • EPS Growth
  • VIVS N/A
  • ICON N/A
  • EPS
  • VIVS N/A
  • ICON N/A
  • Revenue
  • VIVS $144,000.00
  • ICON $5,309,000.00
  • Revenue This Year
  • VIVS $42.38
  • ICON $51.78
  • Revenue Next Year
  • VIVS $15.42
  • ICON $51.90
  • P/E Ratio
  • VIVS N/A
  • ICON N/A
  • Revenue Growth
  • VIVS 32.11
  • ICON 18.61
  • 52 Week Low
  • VIVS $1.41
  • ICON $1.60
  • 52 Week High
  • VIVS $21.96
  • ICON $154.00
  • Technical
  • Relative Strength Index (RSI)
  • VIVS N/A
  • ICON N/A
  • Support Level
  • VIVS N/A
  • ICON N/A
  • Resistance Level
  • VIVS N/A
  • ICON N/A
  • Average True Range (ATR)
  • VIVS 0.00
  • ICON 0.00
  • MACD
  • VIVS 0.00
  • ICON 0.00
  • Stochastic Oscillator
  • VIVS 0.00
  • ICON 0.00

About VIVS VivoSim Labs Inc. Common Stock

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

About ICON Icon Energy Corp. Common stock

Icon Energy Corp is a growth-oriented shipping company providing seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels. The company generates its revenues by chartering its vessels to regional and international dry bulk operators, commodity traders and end users.

Share on Social Networks: